Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis

Topping, 2001, Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides, Physiol Rev, 81, 1031, 10.1152/physrev.2001.81.3.1031 Ramos, 1997, Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets, Nutr Cancer, 28, 212, 10.1080/01635589709514577 Kanauchi, 1999, Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model, J Gastroenterol Hepatol, 14, 1173, 10.1046/j.1440-1746.1999.02025.x Patz, 1996, Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas, Am J Gastroenterol, 91, 731 Scheppach, 1996, Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German–Austrian SCFA Study Group, Dig Dis Sci, 41, 2254, 10.1007/BF02071409 Scheppach, 1992, Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis, Gastroenterology, 103, 51, 10.1016/0016-5085(92)91094-K Kanauchi, 1999, Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model, J Gastroenterol Hepatol, 14, 880, 10.1046/j.1440-1746.1999.01971.x Videla, 2001, Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat, Am J Gastroenterol, 96, 1486, 10.1111/j.1572-0241.2001.03802.x Roda, 2007, A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon, World J Gastroenterol, 13, 1079, 10.3748/wjg.v13.i7.1079 Di Sabatino, 2005, Oral butyrate for mildly to moderately active Crohn's disease, Aliment Pharmacol Ther, 22, 789, 10.1111/j.1365-2036.2005.02639.x Vernia, 2000, Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis randomized. Double-blind, placebo-controlled pilot study, Dig Dis Sci, 45, 976, 10.1023/A:1005537411244 Smirick-Tjardes, 2003, Dietary galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal bacterial concentrations, and ileal fermentive characteristics of growing pigs, J Anim Sci, 81, 2535, 10.2527/2003.81102535x Reeves, 1993, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr, 123, 1939, 10.1093/jn/123.11.1939 Lefrancois, 1990, Extrathymic selection of TCR gamma delta+T cells by class II major histocompatibility complex molecules, Cell, 63, 333, 10.1016/0092-8674(90)90166-C Werner, 1992, Measurement of MPO activity as model for detection of granulocyte infiltration in different tissues, Agents Actions, 38 Van Nuenen, 2005, The influence of microbial metabolites on human intestinal epithelial cells and macrophages in vitro, FEMS Immunol Med Microbiol, 45, 183, 10.1016/j.femsim.2005.03.010 Venkatraman, 2003, Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB, Am J Physiol Gastrointest Liver Physiol, 285, G177, 10.1152/ajpgi.00307.2002 Wirtz, 2007, Mouse models of inflammatory bowel disease, Adv Drug Deliv Rev, 59, 1073, 10.1016/j.addr.2007.07.003 Elson, 2005, Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota, Immunol Rev, 206, 260, 10.1111/j.0105-2896.2005.00291.x Aguilar-Nascimento, 2006, Intraluminal injection of short chain fatty acids diminishes intestinal mucosa injury in experimental ischemia-reperfusion, Acta Cir Bras, 21, 21, 10.1590/S0102-86502006000100006 Wedemeyer, 2008, Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours, Best Pract Res Clin Gastroenterol, 22, 537, 10.1016/j.bpg.2007.12.001 Coppi, 2007, Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease, Inflamm Bowel Dis, 13, 211, 10.1002/ibd.20018 Lampinen, 2008, Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis, J Leukoc Biol, 84, 1392, 10.1189/jlb.0807513 Rothenberg, 2004, Eosinophilic gastrointestinal disorders (EGID), J Allergy Clin Immunol, 113, 11, 10.1016/j.jaci.2003.10.047 Rothenberg, 2001, Gastrointestinal eosinophils, Immunol Reviews, 179, 139, 10.1034/j.1600-065X.2001.790114.x Wolever, 1996, Serum acetate:propionate ratio is related to serum cholesterol in men but not women, J Nutr, 126, 2790 Kaneko, 2007, Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors, Int Arch Allergy Immunol, 143, 28, 10.1159/000101401 Bailon, 2010, Butyrate in vitro immune modulatory effects might be mediated through a proliferation-related induction of apoptosis, Immunology Cavaglieri, 2003, Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes, Life Sci, 73, 1683, 10.1016/S0024-3205(03)00490-9 Brandtzaeg, 2006, The B-cell system in inflammatory bowel disease, Adv Exp Med Biol, 579, 149, 10.1007/0-387-33778-4_10 Ahrens, 2008, Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis, J Immunol, 181, 7390, 10.4049/jimmunol.181.10.7390 Strober, 2007, The fundamental basis of inflammatory bowel disease, J Clin Invest, 117, 514, 10.1172/JCI30587 Faria, 2005, Oral tolerance, Immunol Rev, 206, 232, 10.1111/j.0105-2896.2005.00280.x Koruda, 1990, Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats, Am J Clin Nutr, 51, 685, 10.1093/ajcn/51.4.685 Koruda, 1988, Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection, Gastroenterology, 95, 715, 10.1016/S0016-5085(88)80019-2 Tian, 2009, Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome, Am J Physiol Gastrointest Liver Physiol, 296, G348, 10.1152/ajpgi.90233.2008